Patents by Inventor Bryan F. Cox

Bryan F. Cox has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antiviral agents and nucleoside analogs for treatment of Zika virus
    Patent number: 11963972
    Abstract: The present invention is directed to compounds, compositions and methods for treating or preventing Zika virus. The compounds include pyrimidine and purine nucleosides and prodrugs thereof, including certain N4-hydroxycytidine nucleoside derivatives, sulfasalazine, and various entry inhibitors.
    Type: Grant
    Filed: March 22, 2017
    Date of Patent: April 23, 2024
    Assignee: Emory University
    Inventors: Raymond F. Schinazi, Franck Amblard, Bryan D. Cox, Leda Bassit, Longhu Zhou, Christina Gavegnano
  • CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS
    Publication number: 20230374523
    Abstract: Embodiments of the present invention provide for methods of treating cancer and methods of delivering toll-like receptor (TLR) agonists to solid tumors in the pancreas using a locoregional therapy through the vasculature. In one aspect, the present invention relates to a method of treating pancreatic cancer comprising administering TLR agonists to the pancreas.
    Type: Application
    Filed: September 21, 2021
    Publication date: November 23, 2023
    Applicant: TriSalus Life Sciences, Inc.
    Inventors: Steven C. Katz, Bryan F. Cox, David Benjamin Jaroch
  • CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS
    Publication number: 20230364125
    Abstract: Embodiments of the present invention provide for methods of treating cancer and methods of delivering toll-like receptor (TLR) agonists to solid tumors in the liver using a locoregional therapy through the vasculature. In one aspect, the present invention relates to a method of treating metastases of uveal melanoma of the liver comprising administering TLR9 agonists to the liver.
    Type: Application
    Filed: September 21, 2021
    Publication date: November 16, 2023
    Applicant: TriSalus Life Sciences, Inc.
    Inventors: Steven C. Katz, Bryan F. Cox, David Benjamin Jaroch
  • RAPAMYCIN ANALOG FOR PREVENTION AND/OR TREATMENT OF NEURODEGNERATIVE CONDITIONS
    Publication number: 20210369684
    Abstract: This disclosure relates to a novel rapamycin analogue of Formula I or Formula II, mixtures, methods for its production, and its use in preventing and/or treating a neurodegenerative condition.
    Type: Application
    Filed: February 8, 2019
    Publication date: December 2, 2021
    Applicant: Torcept Therapeutics, Inc.
    Inventors: Timothy S POWERS, Bryan F COX, Richard B MARSHAK
  • RAPAMYCIN ANALOG FOR PREVENTION AND/OR TREATMENT OF NEURODEGNERATIVE CONDITIONS
    Publication number: 20210030726
    Abstract: The present invention relates to a novel rapamycin analogue of Formula (I), mixtures, methods for its production, and its use in preventing and/or treating a neurodegenerative condition.
    Type: Application
    Filed: February 8, 2019
    Publication date: February 4, 2021
    Applicant: Torcept Therapeutics, Inc.
    Inventors: Timothy S Powers, Bryan F Cox, Richard B Marshak
  • RAPAMYCIN ANALOG FOR PREVENTION AND/OR TREATMENT OF CANCER
    Publication number: 20210024542
    Abstract: The present invention relates to a novel rapamycin analogue, mixtures, methods for its production, and its use in cancer therapy (e.g., prevention and/or treatment).
    Type: Application
    Filed: February 8, 2019
    Publication date: January 28, 2021
    Applicant: Torcept Therapeutics, Inc.
    Inventors: Timothy S Powers, Bryan F Cox, Richard B Marshak
  • Rapamycin Analog
    Publication number: 20200131196
    Abstract: The present invention relates to a novel rapamycin analogue (e.g., of Formula I or Formula II), mixtures, methods for its production, and its use in cancer therapy (e.g., prevention and/or treatment).
    Type: Application
    Filed: February 9, 2018
    Publication date: April 30, 2020
    Applicant: Mount Tam Therapeutics, Inc.
    Inventors: Timothy S. Powers, Bryan F. Cox, Richard B. Marshak